About Us

MESSAGE

The spread of DX, including IOT, through the improvement of digital technology has brought convenience and rapid changes to our living environment.The daily life that has been based on labor time as the price is now no longer worth it. Instead, “Simplicity” – “Precision” – “Speed” are pursued for all services that people come in contact with.

The digitalization of medical care, which originated in the U.S., has spurred rapid development competition, transcended corporate boundaries, conducted an engineering-based verification of all aspects of medical care, and created E-Medical.

We have continued research and development of “disease testing technology by exhaled breath” in various approaches with specialized teams in each fields.We have completed clinical trials in Israel, the U.S., and Japan, and have reached the phase of getting FDA approval for medical care device as an in vitro diagnostic product in Japan and other Asian countries.

While surgical and pharmacological treatments for various pathologies are evolving day by day and multidisciplinary treatment is nowadays being provided, our mission is to realize “early pathology detection” for all diseases that affect humans.VOCs System enables a new testing method to detect early pathology that is easy, painless, and time- and location-independent for more people.

CONCEPT

Breast cancer is said to affect one in nine Japanese women.Mammography, a major medical examination for breast cancer, is often avoided because of the exposure to radiation and severe pain.
On the other hand, tumors detected at an Early Stage have a survival rate of over 95% and are curable.
``Easier and Painless`` breast cancer screening

Approximate numbers in breast cancer (%)
Incidence rate among Japanese females
-
Breast cancer screening uptake rate
-
5-year survival rate by cancer stage (%)
Stage I
Stage III
Stage IV

*The above figures are approximate.

Stage I: 99.8% / Stage III,: 80.7% / Stage IV: 38.7%

MISSION

Biomarkers
We continue to identify various biomarkers in exhaled breath and pursue disease analysis for cancer and other disorders.
Elaborate
We achieve the high detection by making full use of the originally developed correction function, improving the accuracy of the analysis, and analyzing the complex composition of specific biomarkers algorithmically.
Universal Service
We aim to promote inspection systems that have high affinity for people and create a society in which more people can enjoy good health.
Company name VOCs Medical JAPAN Co.
Address Otemachi First Square East Tower 4F, 1-5-1 Otemachi, Chiyoda-ku, Tokyo
Capital 45,000,000 yen
Business activities Medical equipment sales business, import/export of related products, storefront sales business, agency business, medical equipment manufacturing